We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $8.76B
1-Year Est. Return 23.12%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+23.12%
3 Year Est. Return
+69.23%
5 Year Est. Return
+84.02%
10 Year Est. Return
+273.29%
AUM
$3.62B
AUM Growth
+$109M
Cap. Flow
+$29.8M
Cap. Flow %
0.82%
Top 10 Hldgs %
13.63%
Holding
1,787
New
81
Increased
723
Reduced
742
Closed
106

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$7.8M
2
DNB
Dun & Bradstreet
DNB
+$6.42M
3
PNC icon
PNC Financial Services
PNC
+$6.23M
4
PEP icon
PepsiCo
PEP
+$5.76M
5
DIS icon
Walt Disney
DIS
+$4.56M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Healthcare 15.13%
3 Technology 14.47%
4 Industrials 12.84%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
26
Novartis
NVS
$302B
$21.7M 0.6%
290,260
+16,079
+6% +$1.14M
NEE icon
27
NextEra Energy
NEE
$185B
$21.4M 0.59%
611,916
-4,232
-0.7% -$145K
PM icon
28
Philip Morris
PM
$309B
$21.4M 0.59%
181,891
+5,123
+3% +$593K
PFE icon
29
Pfizer
PFE
$143B
$21.1M 0.58%
662,941
-2,661
-0.4% -$83.9K
EFA icon
30
iShares MSCI EAFE ETF
EFA
$76.4B
$20.9M 0.58%
320,464
+58,701
+22% +$3.8M
BAC icon
31
Bank of America
BAC
$429B
$20M 0.55%
826,054
+6,615
+0.8% +$154K
BA icon
32
Boeing
BA
$169B
$19.9M 0.55%
100,592
-18,512
-16% -$3.45M
UNH icon
33
UnitedHealth
UNH
$382B
$19.5M 0.54%
105,209
-9,585
-8% -$1.68M
TRV icon
34
Travelers Companies
TRV
$81.1B
$18.9M 0.52%
149,581
+1,500
+1% +$185K
AMZN icon
35
Amazon
AMZN
$2.44T
$18.9M 0.52%
391,040
-2,900
-0.7% -$138K
GE icon
36
GE Aerospace
GE
$364B
$18.8M 0.52%
145,342
+2,320
+2% +$318K
MRK icon
37
Merck
MRK
$322B
$18.3M 0.51%
299,624
-8,951
-3% -$545K
ABT icon
38
Abbott
ABT
$187B
$17.9M 0.49%
367,665
-12,504
-3% -$566K
UN
39
DELISTED
Unilever NV New York Registry Shares
UN
$17.8M 0.49%
321,206
-32,261
-9% -$1.74M
GOOGL icon
40
Alphabet (Google) Class A
GOOGL
$4.12T
$17.7M 0.49%
380,280
-36,920
-9% -$1.73M
ZBH icon
41
Zimmer Biomet
ZBH
$18.8B
$17.1M 0.47%
137,519
+604
+0.4% +$71.6K
BCE icon
42
BCE
BCE
$20.8B
$17M 0.47%
377,735
+14,777
+4% +$666K
DEO icon
43
Diageo
DEO
$49.6B
$16.6M 0.46%
138,481
+10,512
+8% +$1.25M
HSBC icon
44
HSBC
HSBC
$352B
$16.5M 0.46%
388,733
+15,167
+4% +$589K
WELL icon
45
Welltower
WELL
$174B
$16.4M 0.45%
219,738
+3,215
+1% +$235K
MMM icon
46
3M
MMM
$91.8B
$16.1M 0.44%
92,221
+2,818
+3% +$471K
TEL icon
47
TE Connectivity
TEL
$60B
$15.9M 0.44%
201,587
+13,742
+7% +$1.05M
TSM icon
48
TSMC
TSM
$1.94T
$15.9M 0.44%
453,544
+9,208
+2% +$318K
IJH icon
49
iShares Core S&P Mid-Cap ETF
IJH
$121B
$15.8M 0.44%
454,010
+95,000
+26% +$3.28M
CB icon
50
Chubb
CB
$140B
$15.5M 0.43%
106,895
+1,041
+1% +$147K

Similar funds

Oppenheimer Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Oppenheimer Asset Management held 1,787 positions worth $3.62B, up 3.1% from $3.51B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer Asset Management's Q2 2017 filing shows 81 new, 723 increased, 742 reduced and 106 closed positions. Its largest new stake was Evolent Health: 58,930 shares worth $1.49M. The largest sale was Microsoft, an estimated $7.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • Oppenheimer Asset Management's largest Q2 2017 buy was Evolent Health: 58,930 shares worth $1.49M.
  • Oppenheimer Asset Management added most to Johnson Controls International in Q2 2017, an estimated $9.09M increase.
  • Oppenheimer Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $7.8M.
  • Oppenheimer Asset Management fully exited Nippon Telegraph & Telephone in Q2 2017, selling an estimated $3.36M.
  • Oppenheimer Asset Management's ten largest holdings make up 14% of its $3.62B portfolio in Q2 2017.
  • Oppenheimer Asset Management opened 81 new positions and closed 106 in Q2 2017.
  • Oppenheimer Asset Management's portfolio value rose 3.1% quarter-over-quarter to $3.62B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.